A CHX com ADS apresentou controle da placa bacteriana semelhante à CHX convencional; o manchamento dos dentes foi clinicamente indesejável para a CHX e aceitável para CHX com ADS; a CHX obteve redução significativamente maior de UFC/mL. Os pacientes manifestaram menos alteração no sabor dos alimentos e do sal e menos irritação da mucosa bucal quando utilizaram a CHX com ADS.
REFERÊNCIAS5
1. Löe H, Schiott CR. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodontal Res. 1970:5:79-83. doi: 10.1111/j.1600-0765.1970.tb00696.x
2. Shetty PR, Setty SB, Kamat SS, Aldarti AS, less SS. Comparison of the antigingivitis and antiplaque efficacy of the herboral (herbal extract) mouthwash with chlorhexidine and listerine mouthwashes: a clinical study. Pakistan Oral & Dental Journal. 2013:33:76-81.
3. Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg. 2002: 31(3):309-317. doi: 10.1054/ijom.2002.0263
4. Caso A, Hung LK, Beirne OR. Prevention of alveolar osteitis with chlorhexidine: A meta-analytic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005:99:155- 159. doi:10.1016/j.tripleo.2004.05.009.x
5. Sánchez FR, Andrés CR, Calvo IA. Does Chlorhexidine Prevent Alveolar Osteitis After Third Molar Extractions? Systematic Review and Meta-Analysis. J Oral Maxillofac Surg. 2017: 75(5):901-914. doi: 10.1016/j.joms.2017.01.002.
6. Jones CG. Chlorhexidine: Is it still the gold standard? Periodontol 2000. 1997: 15:55- 62.
7. Elkerbout TA, Slot DE, Van Loveren C, Van der Weijden GA. Will a chlorhexidine-
fluoride mouthwash reduce plaque and gingivitis? Int J Dent Hyg. 2018 Mar 7. doi: 10.1111/idh.12329.
8. Food and Drug Administration: Chlorhexidine- Official information, side effect and use. www.drugs.com; 2011. Available: http://vvvvvi/.drugs.com/pro/chIorhexidine.html
09. Schlett CD, Millar EV, Crawford KB, Cui T, Lanier JB, Tribble DR, Ellis MW. Prevalence of Chlorhexidine-Resistant Methicillin-Resistant Staphylococcus aureus following Prolonged Exposure. Antimicrob Agents Chemother. 2014:58:4404–4410. doi: 10.1128/AAC.02419-14
10. Lim KS, Kam PC. Chlorhexidine--pharmacology and clinical applications. Anaesth Intensive Care. 2008:36:502-512.
11. Gründemann LJ, Timmerman MF, Ijzerman Y, van der Weijden GA, van der Weijden GA. Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. J Clin Periodontol. 2000:27:9-15. doi: 10.1034/j.1600- 051x.2000.027001009.x
12. Claydon N, Addy M, Jackson R, Smith S, Newcombe RG. Studies on the effect of polyvinyl pyrrolidone on the activity of chlorhexidine mouthrinses: plaque and stain. J Clin Periodontol 2001:28:558–564. doi:10.1034/j.1600-051x.2001.028006558.x
13. Bernardi F, Pincelli MR, Carloni S, Gatto MR, Montebugnoli L. Chlorhexidine with an Anti Discoloration System. A comparative study. International. Int J Dent Hyg. 2004:2:122-126. doi:10.1111/j.1601-5037.2004.00083.x
14. Cortellini P, Labriola A, Zambelli R, Prato GP, Nieri M, Tonetti MS. Chlorhexidine with an anti discoloration system after periodontal flap surgery: a cross-over, randomized, triple-blind clinical trial. J Clin Periodontol 2008:35:614–620. doi:10.1111/j.1600-051X.2008.01238.x.
15. Solís C, Santos A, Nart J, Violant D. 0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study. J Periodontol. 2011:82:80-5. doi: 10.1902/jop.2010.100289. 16. Li W, Wang RE, Finger M, Lang NP. Evaluation of the antigingivitis effect of a chlorhexidine mouthwash with or without an antidiscoloration system compared to placebo during experimental gingivitis. J Investig Clin Dent. 2014:5:15-22. doi: 10.1111/jicd.12050
17. Marrelli M, Amantea M, Tatullo M. A comparative, randomized, controlled study on clinical efficacy and dental staining reduction of a mouthwash containing Chlorhexidine 0.20% and Anti Discoloration System (ADS). Annali di Stomatologia. 2015:6:35-42. 18. Silness J, Löe H. Periodontal disease in pregnancy III. Response to local treatment. Acta Odontol Scand. 1966:24:747-759. doi :10.3109/00016356609028739 19. De Oliveira AL, Botta AC, Campos JA, & Garcia PP. Influence of light curing units and fluoride mouthrinse on morphological surface and color stability of a nanofilled composite resin. Microscopy Research and Technique. 2014: 77: 941-946. doi: 10.1002/jemt.22421
20. Um CM, Ruyter IE. Staining of resin-based veneering materials with coffee and tea. Quintessence Int. 1991:22:377-86.
21. Kumar S, Sharma J, Duraiswamy P, Kulkarni S. Determinants for oral hygiene and periodontal status among mentally disabled children and adolescents. J Indian Soc Pedod Prev Dent. 2009 27(3):151-157. doi: 10.4103/0970-4388.57095.
22. Pereira, R.; Phad, S. G. Comparative Evaluation of 0,2% Chlorexidine Mouth: Rinse with and without an Antidiscoloration System: A Clinical Study. Journal of Contemporary Dentistry. 2017:7:53-56. doi: 10.5005/jp-journals-10031-1185
23. Graziani F, Gabriele M, D'Aiuto F, Suvan J, Tonelli M, Cei S. Dental plaque, gingival inflammation and tooth -discolouration with different commercial -formulations of 0.2% chlorhexidine rinse: a double-blind randomised controlled clinical trial. Oral Health Prev Dent. 2015:13:101-111. doi: 10.3290/j.ohpd.a32827
24. Bevilacqua L, Liani G, Castronovo G, Costantinides F. Clinical and spectrophotometric evaluation after chlorhexidine use in periodontal flap surgery: A prospective randomized clinical trial. Am J Dent. 2016:29:75-80
25. Varoni EM, Gargano M, Ludwig N, Lodi G, Sardella A, Carrassi A. Efficacy of na anti-discoloration system (ADS) in a 0.12% chlorhexidine mouthwash: A triple blind, randomized clinical trial. Am J Dent. 2017:30:235-242.
26. Kaushik M, Reddy P, Sharma R, Udameshi P, Mehra N, Marwaha A. The Effect of Coconut Oil pulling on Streptococcus mutans Count in Saliva in Comparison with Chlorhexidine Mouthwash. J Contemp Dent Pract. 2016:17:38-41. doi: 10.5005/jp- journals-10024-1800
27. Guggenheim B, Meier A. In vitro effect of chlorhexidine mouth rinses on polyspecies biofilms. Schweiz Monatsschr Zahnmed. 2011:121:432-441.
28. Arweiler NB, Boehnke N, Sculean A, Hellwig E, Auschill TM. Differences in efficacy of two commercial 0.2% chlorhexidine mouthrinse solutions: a 4 day plaque re-growth study. J Clin Periodontol. 2006:33:334-339. doi:10.1111/j.1600-051X.2006.00917.x 29. Leyes Borrajo JL, Garcia VL, Lopez CG, Rodriguez-Nuñez I, Garcia FM, Gallas TM. Efficacy of chlorhexidine mouthrinses with and without alcohol: a clinical study. J Periodontol. 2002:73:317-321. doi: 10.1902/jop.2002.73.3.317
30. Herrera D, Roldán S, Santacruz I, Santos S, Masdevall M, Sanz M. Differences in antimicrobial activity of four commercial 0.12% chlorhexidine mouthrinse formulations: an in vitro contact test and salivary bacterial counts study. J Clin Periodontol. 2003:30:307-314. doi: 10.1034/j.1600-051X.2003.00341.x
REFERÊNCIAS GERAIS6
ARWEILER, N. B. et al. Differences in efficacy of two commercial 0,2% chlorhexidine mouthrinse solutions: a 4 day plaque re-growth study. Journal of Clinical
Periodontology, v. 33, n. 5, p. 334–339, mai. 2006.
BERNARDI, F. et al. Chlorhexidine with an Anti Discoloration System. A comparative study. International. International Journal of Dental Hygiene, v. 2, n. 3, p. 122–126, ago. 2004.
BEVILACQUA, L. et al. Clinical and spectrophotometric evaluation after chlorhexidine use in periodontal flap surgery: A prospective randomized clinical trial. American
Journal of Dentistry, v. 29, n. 2, p. 75-85, abr. 2016.
BLUM, I. R. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review.
International Journal of Oral & Maxillofacial Surgery, v. 31, n. 3, p. 309-317, jun.
2002.
BOZKUT, F. Y.; ÖZTÜRK, M.; YETKIN, Z. The Effects of Three Oral Sprays on Plaque and Gingival Inflammation. Journal of Periodontology, v. 76, n. 10, p. 1654-1660, out. 2005.
BRECX, M. Strategies and agents in supragingival chemical plaque control.
Periodontology 2000, v. 15, n. 1, p. 100-108, out. 1997.
CASO, A.; HUNG, L. K.; BEIRNE, O. R. Prevention of alveolar osteitis with chlorhexidine: A meta-analytic review. Oral Surgery, Oral Medicine, Oral Pathology,
Oral Radiology and Endodontology, v. 99, n. 2, p. 155–59, fev. 2005.
CLAYDON, N. et al. Studies on the effect of polyvinylpyrrolidone on the activity of chlorhexidine mouthrinses: plaque and stain. Journal of Clinical Periodontology, v. 28, n. 6, p. 558-564, jun. 2001.
6Normas de Padronização Bibliográfica seguindo os Requisitos da ABNT - Associação Brasileira de Normas Técnicas – NBR 6023, de 30/08/2002, em vigor.Disponível em:
CORTELLINI, P. et al. Chlorhexidine with an anti discoloration system after periodontal flap surgery: A cross-over, randomized, triple-blind clinical trial. Journal of Clinical
Periodontology, v. 35, n. 7, p. 614–620, jul. 2008.
DELILBASI, C.; SARACOGLU, U.; KESKIN, A. Effects of 0.2% chlorhexidinegluconate and amoxicillin plus clavulanic acid on the prevention of alveolar osteitis following mandibular third molar extractions. Oral Surgery, Oral Medicine, Oral Pathology,
Oral Radiology, and Endodontics, v. 94, n. 3, p. 301–304, set. 2002.
DE OLIVEIRA, A. L. et al. Influence of light curing units and fluoride mouthrinse on morphological surface and color stability of a nanofilled composite resin. Microscopy
Research and Technique, v. 77, n. 11, p. 941-946, nov. 2014.
ELKERBOUT, T. A. et al. Will a chlorhexidine-fluoride mouthwash reduce plaque and gingivitis? International Journal of Dental Hygiene, v. 7, mar. 2018.
EMILSON, C. G. Susceptibility of various microorganisms to chlorhexidine.
Scandinavian Journal of Dental Research, v. 85, n. 4, p. 255–265, ago. 1977.
ENNIBI, O. et al. Chlorhexidine alcohol base mouthrinse versus Chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: Double blind, randomized clinical trials. Medicina Oral Patologia Oral y Cirugia Bucal, v. 18, n. 1, p. 135-139, jan. 2013.
ERIKSEN, H. M. et al. Chemical plaque control and extrinsic tooth discoloration. A review of possible mechanisms. Journal of clinical periodontology, v. 12, n. 5, p. 345–50, mai. 1985.
ERNST, C. P.; PROCKL, K.; WILLERSHAUSEN, B. The effectiveness and side effects of 0,1% and 0,2% chlorhexidine mouthrinses: a clinical study. Quintessence
International, v. 29, n. 7, p. 443-448, jul. 1998.
EVANS, A. et al. Interference of Antimicrobial Activity of Combinations of Oral
Antiseptics Against Streptococcus mutans, Streptococcus sanguinis, and
FARDAI, O.; TURNBULL, R. S. A review of the literature on use of chlorhexidine in dentistry. The Journal of the American Dental Association, v. 112, n. 6, p. 863-869, jun. 1986.
FAVERI, M. et al. Scaling and root planing and chlorhexidine mouthrinses in the treatment of chronic periodontitis: A randomized, placebo-controlled clinical trial.
JournalofClinicalPeriodontology, v. 33, n. 11, p. 819-828, nov. 2006.
FDA. www.drugs.com. Chlorhexidine- FDA Official Information, side effect and Use. www.drugs.com; 2011. Available: http://vvvvvi/.drugs.com/pro/chIorhexidine.html GRAZIANI, F. et al. Dental Plaque, Gingival Inflammation and Tooth Discolouration with Different Commercial Formulations of 0.2% Chlorhexidine Rinse: A Double-blind Randomised Controlled Clinical Trial. Oral Health & Preventive Dentistry, v. 13, n. 2, p. 101-111, abr. 2015.
GRUNDEMANN, L. J. et al. Stain, plaque and gingivitis reduction by combining chlorhexidine and peroxyborate. Journal Clinical Periodontology, v. 27, n. 1, p. 9– 15, jan. 2000.
GUGGENHEIM, B.; MEIER, A. In vitro effect of chlorhexidine mouth rinses on polyspecies biofilms. SchweizMonatsschrZahnmed, v. 121, n. 5, p. 432–441, mai. 2011.
HERMESCH, C. B. et al. Perioperative use of 0.12% chlorhexidinegluconate for the prevention of alveolar osteitis: efficacy and risk factor analysis. Oral surgery, oral
medicine, oral pathology, oral radiology, and endodontics, v. 85, n. 4, p. 381–387,
abr. 1998.
HERRERA, D. et al. Differences in antimicrobial activity of sour commercial 0.12% chlorhexidinemouthrinse formulations: an in vitro contact test and salivary bacterial counts study. Journal of Clinical Periodontology, v. 30, n. 4, p. 307-314, abr. 2003. JONES, C. G. Chlorhexidine: Is it still the gold standard? Journal Periodontol 2000, v. 15, n. 1, p. 55-62, out. 1997.
JURIŠIĆ, S. et al. The influence of different types of brackets and efficacy of two chlorhexidine mouthwashes on oral hygiene and the incidence of white spot lesions in adolescents during the orthodontic therapy. Medicina AcademicaMostariensia, v. 4, n. 1-2, p. 63-68, 2016.
KAUSHIK, M. et al. The Effect of Coconut Oil pulling on Streptococcus mutans Count in Saliva in Comparison with Chlorhexidine Mouthwash. Journal of Contemporary Dental Practice, v. 17, n. 1, p. 38-41, jan. 2016.
KOO, H. et al. Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats. Oral Microbiology and Immunology, v. 17, n. 6, p. 337–343, dez. 2002.
KUMAR, S. et al. Determinants for oral hygiene and periodontal status among mentally disabled children and adolescents. Journal of Indian Society of Pedodontics and
Preventive Dentistry, v. 27, n. 3, p. 151-157, out. 2009.
LEYES BORRAJO, J. L. et al. Efficacy of chlorhexidine mouthrinses with and without alcohol: a clinical study. Journal of Periodontology, v. 73, n. 3, p. 317-321, mar. 2002.
LI, W. et al. Evaluation of the antigingivitis effect of a chlorhexidine mouthwash with or without an antidiscoloration system compared to placebo during experimental gingivitis. Journal of Investigative and Clinical Dentistry, v. 5, n. 1, p. 15-22, fev. 2014.
LIM, K.S.; KAM, P. C. A. Chlorhexidine - pharmacology and clinical applications.
Anaesthesia and Intensive Care, v.36, n.4, p. 502-512, jul. 2008.
LOE, H.; SCHIOTT, C. R. The effect of mouthrinses and topical ap- plication of chlorhexidine on the development of dental plaque and gingivitis in man. Journal of
Periodontal Research, v. 5, n. 2, p. 79-83, abr. 1970.
MALTZ-TURKIENICZ, M.; KRASSE, B.; EMILSON, C. G. Effects of chlorhexidine and iodine on in vitro plaques of Streptococcus mutans and Streptococcus sanguis.
MARRELLI, M.; AMANTEA, M.; TATULLO, M. A comparative, randomized, controlled study on clinical efficacy and dental staining reduction of a mouthwash containing Chlorhexidine 0,20 % and Anti Discoloration System (ADS). Annali di Stomatologia, v. 6, n. 2, p. 35–42, abr-jun. 2015.
PEREIRA, R.; PHAD, S. G. Comparative Evaluation of 0,2% Chlorexidine Mouth: Rinse with and without an Antidiscoloration System: A Clinical Study. Journal of Contemporary Dentistry, v. 7, n. 1, p. 53-56, jan-abr. 2017.
SÁNCHEZ, F. R.; ANDRÉS, C. R.; CALVO, I. A. Does Chlorhexidine Prevent Alveolar Osteitis After Third Molar Extractions? Systematic Review and Meta-Analysis. Journal of Oral and Maxillofacial Surgery, v. 75, n. 5, p. 901-914, mai. 2017.
SANTOS, A. Evidence-based control of plaque and gingivitis. Journal of Clinical
Periodontology, v. 30, s. 5, p. 13-16, jun. 2003.
SCHLETT, C. D. et al. Prevalence of Chlorhexidine-Resistant Methicillin-Resistant Staphylococcus aureus following Prolonged Exposure. Antimicrobial Agents
Chemotherapy, v. 58, n. 8, p. 4404–10, ago. 2014.
SHETTY, P. R. et al. Comparison of the antigingivitis and antiplaque efficacy of the herboral (herbal extract) mouthwash with chlorhexidine and listerine mouthwashes: a clinical study. Pakistan Oral & Dental Journal, v. 33, n. 1, p. 76-81, abr. 2013. SILNESS, J.; LÖE, H. Periodontal disease in pregnancy III. Response to local treatment. ActaOdontologicaScandinavica, v. 24, n. 6, p.747-759, 1966.
SOLIS, C. et al. 0.2% chlorhexidine mouthwash with an antidiscoloration system versus 0.2% chlorhexidine mouthwash: a prospective clinical comparative study.
Journal of Periodontology, v. 82, n. 1, p. 80–85, jan. 2011.
UM, C.M; RUYTER, I.E. Staining of resin-based veneering materials with coffee and tea. Quintessence International, v. 22, n. 5, p. 377–386, 1991.
VARONI, E. M. et al. Efficacy of na anti-discoloration system (ADS) in a 0,12% chlorhexidine mouthwash: A triple blind, randomized clinical trial. American Journalof
ANEXO A - Normas da Revista: International Journal of Oral and Maxillofacial Surgery
Editorial Policy
A paper is accepted for publication on the understanding that it has not been submitted simultaneously to another journal, has been read and approved by all authors, and that the work has not been published before. The Editors reserve the right to make editorial and literary corrections. Any opinions expressed or policies advocated do not necessarily reflect the opinions and policies of the Editors.
Declarations
Upon submission you will be required to complete and upload the declarations page (pdf version or word version) to declare funding, conflict of interest and to indicate that ethical approval was given – all studies involving patients must have patient consent and ethical committee approval, please refer to the section on ‘Ethics’ below. This information must also be inserted into your manuscript under the acknowledgements section with the headings below.Upon submission you will be required to complete and upload this form (pdf version or word version) to declare funding, conflict of interest, and to indicate whether ethical approval and patient consent were given and you must also upload with it the IRB approval or exemption letter. This applies to original research articles carried out on humans, including observational studies and case series. Ethical committee approval or exemption is not needed for systematic review articles or articles that are not based on humans or animals. Research on animal studies should be uploaded with the appropriate ethical approval for the study. If the ethical approval or exemption letter is not in English please provide the text in English. Lastly you must confirm that all authors have agreed to the submission.
PLEASE NOTE that all funding must be declared at first submission, as the addition of funding at acceptance stage may invalidate the acceptance of your manuscript.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data (2) drafting the article or revising it critically for important intellectual content (3) final approval of the version to be submitted. Normally one or two, and no more than three, authors should appear on a short communication, technical note or interesting case/lesson learnt. Full length articles may contain as many authors as appropriate. Minor contributors and non-contributory clinicians who have allowed their patients to be used in the paper should be acknowledged at the end of the text and before the references.
The corresponding author is responsible for ensuring that all authors are aware of their obligations. Before a paper is accepted all the authors of the paper must sign the Confirmation of Authorship form. This form confirms that all the named authors agree to publication if the paper is accepted and that each has had significant input into the paper. Please download the form and send it to the Editorial Office. (pdf version or word version) It is advisable that to prevent delay this form is submitted early in the editorial process.
Acknowledgements
All contributors who do not meet the criteria for authorship as defined above should be listed in an acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair who provided only general support. Authors should disclose whether they had any writing assistance and identify the entity that paid for this assistance.
Conflict of interest
At the end of the main text, all authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. If an author has no conflict of interest to declare, this should be stated.
Role of the funding source
All sources of funding should be declared as an acknowledgement at the end of the text. Authors should declare the role of study sponsors, if any, in the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state.
Ethics
Any manuscript concerned with human subjects, medical records, or human tissue that is submitted to the International Journal of Oral and Maxillofacial Surgery should comply with the principles stated in the Declaration of Helsinki “Ethical Principles for Medical Research Involving ‘Human Subjects”, adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, and as amended most recently by the 64th World Medical Assembly, Fontaleza, Brazil, October 2013.
The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was performed, and that subjects gave informed consent to the work. The International Journal of Oral and Maxillofacial Surgery requires institutional Ethics Committee approval for all human studies. For retrospective studies of records either a statement of approval or a statement of exemption from the Committee is appropriate. This statement should be provided upon submission of the manuscript.
Studies involving experiments with animals must state that their care was in accordance with institution guidelines.
Patient confidentiality
Patients have a right to privacy. Therefore identifying information, including patients' images, names, initials, or hospital numbers, should not be included in videos, recordings, written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and you have obtained written informed consent for publication in print and electronic form from the patient (or parent, guardian or next of kin where applicable). If such consent is made subject to any conditions, The Editor and Publisher must be made aware of all such conditions. Written consents must be provided to the Editorial Office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.If consent for publication has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission.
Registration of clinical trials
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which
the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
RESEARCH DATA
This journal encourages and enables you to share data that supports your research publication where appropriate, and enables you to interlink the data with your published articles. Research data refers to